Total planned funding: $324,708,599
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $91,890,692 |
| Mozambique | $49,507,134 |
| Zambia | $39,876,008 |
| Kenya | $20,255,118 |
| Vietnam | $14,945,295 |
| Burundi | $12,663,441 |
| Botswana | $11,109,397 |
| Haiti | $9,408,813 |
| Tanzania | $8,262,279 |
| Côte d'Ivoire | $7,938,330 |
| India | $7,773,000 |
| Indonesia | $7,101,155 |
| Ghana | $6,982,500 |
| South Africa | $5,719,826 |
| South Sudan | $3,920,883 |
| Asia Regional Program | $3,654,954 |
| Democratic Republic of the Congo | $3,641,200 |
| Papua New Guinea | $3,189,171 |
| Caribbean Region | $2,717,206 |
| Rwanda | $2,594,238 |
| Malawi | $2,422,000 |
| Central America Region | $1,646,143 |
| Namibia | $1,497,275 |
| Uganda | $1,468,804 |
| Ethiopia | $1,105,000 |
| Angola | $1,085,000 |
| Eswatini | $833,737 |
| Cameroon | $700,000 |
| Dominican Republic | $500,000 |
| Central Asia Region | $300,000 |
| Lesotho | $0 |
| Cambodia | $0 |
Organizational Types
| NGO | $324,708,599 |
Program Areas
| Care | $108,982,973 |
| Prevention | $88,636,707 |
| Treatment | $76,511,761 |
| Governance and Systems | $29,887,499 |
| Testing | $20,689,659 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $67,535,259 |
| HBHC: Care: Adult Care and Support | $56,045,760 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $37,232,504 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $35,977,242 |
| HKID: Care: Orphans and Vulnerable Children | $33,531,187 |
| HVCT: Testing: HIV Testing and Counseling | $20,689,659 |
| HVTB: Care: TB/HIV | $10,773,116 |
| OHSS: Health Systems Strengthening | $10,344,819 |
| HLAB: Laboratory Infrastructure | $9,803,399 |
| HVSI: Strategic Information | $9,739,281 |
| PDTX: Treatment: Pediatric Treatment | $8,976,502 |
| PDCS: Care: Pediatric Care and Support | $8,632,910 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $6,439,575 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,776,399 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,664,048 |
| HMIN: Biomedical Prevention: Injection Safety | $418,391 |
| HMBL: Biomedical Prevention: Blood Safety | $128,548 |
| HTXD: Treatment: ARV Drugs | $0 |